Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3))

Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.
Supplier Selleck Chemicals
Product # A3065
Sku # A3065-1mg*25
Pricing 1mg*25, $5070.00
Feedback